TapewireFind a company

person · Reporting owner

SOMERS KIRK

Disclosed activity across 1 company

Tapewire entity
125281
SEC CIK
0001204015

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Cardlytics, Inc.CDLX · Entity 7603Chief Legal & Privacy OfficerJune 09, 2022July 20, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cardlytics, Inc.

Report date June 09, 2022 · Filed July 20, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect52,130 Ending reported balance After 2022-07-20 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2022-06-09 · Exercise / conversion · Acquired 7,813 · Balance 53,130

F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

Row 2 · 2022-07-20 · Sale · Disposed 1,000 · Balance 52,130

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.

Performance Stock UnitSEC Table II · derivative / convertible securityDirect7,812 Reported balance After 2022-06-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2022-06-09 · Exercise / conversion · Disposed 7,813 · Balance 7,812

F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.

F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 17, 2020 Filed Jan 18, 2020 00:34 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 919 $84.88 $78,004.72
Disclosure

SEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 4

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,893

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $84.86 to $84.99, inclusive.

Read SEC document
January 17, 2020 Filed Jan 18, 2020 00:34 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 450 $84.13 $37,858.50
Disclosure

SEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,812

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $83.86 to $84.21, inclusive.

Read SEC document
January 17, 2020 Filed Jan 18, 2020 00:34 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 5,409 $83.06 $449,271.54
Disclosure

SEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,262

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $82.83 to $83.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
January 17, 2020 Filed Jan 18, 2020 00:34 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 778 $20.00 $15,560.00
Disclosure

SEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,671

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019.

Read SEC document
December 17, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 GiftCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 6

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,893

F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration.

Read SEC document
December 17, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 GiftCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 5

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,093

F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $30.44 $0.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · derivative · entry 9

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 10,000 shares

Expires 2027-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 261 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · derivative · entry 8

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

Underlying: Common Stock · 261 shares

Expires 2026-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 777 $0.00 Strike: $9.08 $0.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · derivative · entry 7

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 777 shares

Expires 2024-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 11,038 $58.00 $640,204.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 4

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,293

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 10,000 $30.44 $304,400.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 261 $20.00 $5,220.00
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:21 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 777 $9.08 $7,055.16
Disclosure

SEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 13:54 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $30.44 $0.00
Disclosure

SEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · derivative · entry 5

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 15,000 shares

Expires 2027-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 13:54 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 25,231 $0.00 Strike: $9.08 $0.00
Disclosure

SEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · derivative · entry 4

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 777

Underlying: Common Stock · 25,231 shares

Expires 2024-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 13:54 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 15,000 $60.00 $900,000.00
Disclosure

SEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,293

Read SEC document
December 03, 2019 Filed Dec 5, 2019 13:54 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 15,000 $30.44 $456,600.00
Disclosure

SEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 13:54 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 25,231 $9.08 $229,097.48
Disclosure

SEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 5,426 $56.22 $305,049.72
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 7

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,062

F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of the performance stock units.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.77, inclusive.

Read SEC document
November 26, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 10,100 $55.88 $564,388.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 6

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,488

F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of the performance stock units.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.73 to $55.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 15,625 $0.00 $0.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 13

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Common Sock · 15,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F9 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019, twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification.

F9 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019, twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionPerformance Stock Unit · Derivative 15,625 $0.00 $0.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 12

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,875

Underlying: Common Sock · 15,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F8 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification.

F8 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 31,250 $0.00 $0.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 11

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Sock · 31,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F8 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification.

F8 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 9,114 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 10

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,386

Underlying: Common Sock · 9,114 shares

Expires 2026-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 22,671 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 9

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,664

Underlying: Common Sock · 22,671 shares

Expires 2026-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,491 $0.00 Strike: $9.08 $0.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 8

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,008

Underlying: Common Stock · 1,491 shares

Expires 2024-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 15,625 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 5

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,588

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 15,625 Not disclosed Not disclosed
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 4

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,963

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 33,276 $56.38 $1,876,100.88
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,338

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 31,785 $20.00 $635,700.00
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 25, 2019 Filed Nov 28, 2019 00:12 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 1,491 $9.08 $13,538.28
Disclosure

SEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2019 Filed Nov 21, 2019 22:04 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,500 $58.70 $88,050.00
Disclosure

SEC source: 0001666071-19-000154 · wf-form4_157437382910540.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,338

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.

F2 · balance_after: Includes 555 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
October 21, 2019 Filed Oct 21, 2019 20:41 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,500 $38.15 $57,225.00
Disclosure

SEC source: 0001666071-19-000130 · wf-form4_157169042183244.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,283

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.

Read SEC document
September 30, 2019 Filed Sep 30, 2019 20:30 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $9.08 $0.00
Disclosure

SEC source: 0001666071-19-000124 · wf-form4_156987542066830.xml · derivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,499

Underlying: Common Stock · 10,000 shares

Expires 2024-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
September 30, 2019 Filed Sep 30, 2019 20:30 UTC Cardlytics, Inc. CDLX · Entity 7603 Exercise / conversionCommon Stock 10,000 $9.08 $90,800.00
Disclosure

SEC source: 0001666071-19-000124 · wf-form4_156987542066830.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,783

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 20, 2019 Filed Sep 23, 2019 13:04 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,500 $35.41 $53,115.00
Disclosure

SEC source: 0001666071-19-000117 · wf-form4_156924384913468.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,783

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.

Read SEC document
August 26, 2019 Filed Aug 28, 2019 21:04 UTC Cardlytics, Inc. CDLX · Entity 7603 GrantPerformance Stock Unit · Derivative 31,250 $0.00 $0.00
Disclosure

SEC source: 0001666071-19-000105 · wf-form4_156702622063543.xml · derivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Common Sock · 31,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the first tranche of the PSU to be awarded, which shares are reflected in Column 5 above. Fifty percent (50%) of the shares subject to the first tranche of the PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 12 months after the Certification. The PSU has not yet settled.

F2 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the first tranche of the PSU to be awarded, which shares are reflected in Column 5 above. Fifty percent (50%) of the shares subject to the first tranche of the PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 12 months after the Certification. The PSU has not yet settled.

Read SEC document
August 20, 2019 Filed Aug 21, 2019 20:03 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,500 $32.57 $48,855.00
Disclosure

SEC source: 0001666071-19-000094 · wf-form4_156641778134365.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,283

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:52 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,500 $27.46 $41,190.00
Disclosure

SEC source: 0001666071-19-000070 · wf-form4_156400150426705.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,783

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $27.41 to $27.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 14:56 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 1,500 $24.05 $36,075.00
Disclosure

SEC source: 0001666071-19-000051 · wf-form4_156112896646829.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,283

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $23.85 to $24.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · balance_after: Includes 944 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
March 29, 2019 Filed Mar 29, 2019 20:53 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 820 $16.52 $13,546.40
Disclosure

SEC source: 0001209191-19-021787 · doc4.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,839

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.62, inclusive.

Read SEC document
March 28, 2019 Filed Mar 29, 2019 20:53 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 831 $16.30 $13,545.30
Disclosure

SEC source: 0001209191-19-021787 · doc4.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,659

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.03 to $16.42, inclusive.

Read SEC document
March 27, 2019 Filed Mar 29, 2019 20:53 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 857 $15.79 $13,532.03
Disclosure

SEC source: 0001209191-19-021787 · doc4.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,490

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.78 to $15.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
March 26, 2019 Filed Mar 26, 2019 20:46 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 862 $15.70 $13,533.40
Disclosure

SEC source: 0001209191-19-021336 · doc4.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,347

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.67 to $15.83, inclusive.

Read SEC document
March 25, 2019 Filed Mar 26, 2019 20:46 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 887 $15.26 $13,535.62
Disclosure

SEC source: 0001209191-19-021336 · doc4.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,209

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.12 to $15.40, inclusive.

Read SEC document
March 22, 2019 Filed Mar 26, 2019 20:46 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 846 $16.00 $13,536.00
Disclosure

SEC source: 0001209191-19-021336 · doc4.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,096

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.77 to $16.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
March 21, 2019 Filed Mar 21, 2019 21:17 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 851 $15.91 $13,539.41
Disclosure

SEC source: 0001209191-19-020806 · doc4.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,942

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.89 to $16.156, inclusive.

Read SEC document
March 20, 2019 Filed Mar 21, 2019 21:17 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 874 $15.49 $13,538.26
Disclosure

SEC source: 0001209191-19-020806 · doc4.xml · nonDerivative · entry 2

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,793

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.48 to $15.63, inclusive.

Read SEC document
March 19, 2019 Filed Mar 21, 2019 21:17 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 866 $15.63 $13,535.58
Disclosure

SEC source: 0001209191-19-020806 · doc4.xml · nonDerivative · entry 1

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,667

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.63 to $15.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
March 18, 2019 Filed Mar 18, 2019 21:04 UTC Cardlytics, Inc. CDLX · Entity 7603 SaleCommon Stock 871 $15.54 $13,535.34
Disclosure

SEC source: 0001209191-19-020036 · doc4.xml · nonDerivative · entry 3

SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,533

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.54 to $15.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.